CRISPR Therapeutics AG (CRSP): Price and Financial Metrics
CRISPR Therapeutics AG (CRSP)
Today's Latest Price: $38.50 USD
3.91 (-9.22%)
Updated Apr 1 6:55pm
Add CRSP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CRSP Stock Summary
- The price/operating cash flow metric for CRISPR Therapeutics AG is higher than 95.23% of stocks in our set with a positive cash flow.
- CRSP's price/sales ratio is 8.96; that's higher than the P/S ratio of 90.99% of US stocks.
- Revenue growth over the past 12 months for CRISPR Therapeutics AG comes in at 9,169.85%, a number that bests 99.84% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to CRISPR Therapeutics AG are RGLS, STML, CLSD, ARNA, and SLGL.
- CRSP's SEC filings can be seen here. And to visit CRISPR Therapeutics AG's official web site, go to crisprtx.com.
CRSP Daily Price Range
CRSP 52-Week Price Range
CRSP Stock Price Chart More Charts
CRSP Price/Volume Stats
| Current price | $38.50 | 52-week high | $74.00 |
| Prev. close | $42.41 | 52-week low | $32.30 |
| Day low | $38.35 | Volume | 963,200 |
| Day high | $42.08 | Avg. volume | 1,074,952 |
| 50-day MA | $49.24 | Dividend yield | N/A |
| 200-day MA | $51.00 | Market Cap | 2.34B |
CRISPR Therapeutics AG (CRSP) Company Bio
CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland.
Loading social stream, please wait...